Malignant Plasma Cell Neoplasm Clinical Trials in Houston, Texas

Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy for Relapsed Refractory Multiple Myeloma